Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01266824 · ClinicalTrials.gov registry record · NA
Proparacaine and Mydriatic Eye Drops
A NA study, sponsored by Children's Hospital of Philadelphia.
- Terminated
- Registry status
- NA
- Development phase
- 5
- Enrollment target
NCT01266824 is a NA study that was terminated before completion, run by Children's Hospital of Philadelphia. The registered enrollment target is 5 participants.
The verdict
NCT01266824, a NA study, was terminated before completion, sponsored by Children's Hospital of Philadelphia.
- TERMINATED
- Registry status
- NA
- Development phase
- 5 participants
- Enrollment target
Study Summary
In this study, we will be evaluating whether premedication with an anesthetic eye drops leads to a decreased sensation of pain when given dilating eye drops prior to eye examinations to evaluate for retinopathy of prematurity in neonatal intensive care unit (NICU) infants.
Interventions
- DRUG Proparacaine Hydrochloride Ophthalmic Solution
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2010-12 |
| Est. Completion | 2011-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01266824
The ClinicalTrials.gov registry entry for NCT01266824 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Children's Hospital of Philadelphia, which has 431 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Proparacaine Hydrochloride Ophthalmic Solution is the first listed.
NCT01266824 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01266824 about?
NCT01266824 is a clinical study titled "Proparacaine and Mydriatic Eye Drops". In this study, we will be evaluating whether premedication with an anesthetic eye drops leads to a decreased sensation of pain when given dilating eye drops prior to eye examinations to evaluate for retinopathy of prematurity in neonatal intensive care unit (NICU) infants.
What is the current status of trial NCT01266824?
This trial is currently terminated. It is a NA study. The enrollment target is 5 participants. The study started on 2010-12. Estimated completion is 2011-08.
What interventions are being tested in trial NCT01266824?
The interventions under investigation include: Proparacaine Hydrochloride Ophthalmic Solution (DRUG).
Who is sponsoring clinical trial NCT01266824?
This trial is sponsored by Children's Hospital of Philadelphia, which has 431 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.